Cite
MLA Citation
C. Diefenbach et al.. “POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS.” Hematological oncology, vol. 37, n.d., pp. 175–176. http://access.bl.uk/ark:/81055/vdc_100086193103.0x000044